IN2014MN00955A - - Google Patents
Info
- Publication number
- IN2014MN00955A IN2014MN00955A IN955MUN2014A IN2014MN00955A IN 2014MN00955 A IN2014MN00955 A IN 2014MN00955A IN 955MUN2014 A IN955MUN2014 A IN 955MUN2014A IN 2014MN00955 A IN2014MN00955 A IN 2014MN00955A
- Authority
- IN
- India
- Prior art keywords
- immunomodulator
- therapy
- ultrasound
- embolisation
- cyberknife
- Prior art date
Links
- 239000002955 immunomodulating agent Substances 0.000 abstract 2
- 230000002584 immunomodulator Effects 0.000 abstract 2
- 229940121354 immunomodulator Drugs 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 239000007924 injection Substances 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 238000002604 ultrasonography Methods 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010020843 Hyperthermia Diseases 0.000 abstract 1
- 238000000315 cryotherapy Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000010102 embolization Effects 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 230000036031 hyperthermia Effects 0.000 abstract 1
- 230000037449 immunogenic cell death Effects 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 238000002428 photodynamic therapy Methods 0.000 abstract 1
- 238000007674 radiofrequency ablation Methods 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Radiology & Medical Imaging (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Radiation-Therapy Devices (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1120779.2A GB201120779D0 (en) | 2011-12-02 | 2011-12-02 | Cancer therapy |
| PCT/GB2012/052992 WO2013079980A1 (en) | 2011-12-02 | 2012-12-03 | Immunogenic treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00955A true IN2014MN00955A (enExample) | 2015-04-24 |
Family
ID=45509083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN955MUN2014 IN2014MN00955A (enExample) | 2011-12-02 | 2012-12-03 |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20140356397A1 (enExample) |
| EP (1) | EP2785361B1 (enExample) |
| JP (1) | JP6085611B2 (enExample) |
| KR (1) | KR20140097419A (enExample) |
| CN (1) | CN104023733A (enExample) |
| AU (1) | AU2012343536B2 (enExample) |
| BR (1) | BR112014012880A2 (enExample) |
| CA (1) | CA2857429A1 (enExample) |
| GB (1) | GB201120779D0 (enExample) |
| IL (1) | IL232890A0 (enExample) |
| IN (1) | IN2014MN00955A (enExample) |
| MX (1) | MX2014006511A (enExample) |
| RU (1) | RU2014121335A (enExample) |
| SG (1) | SG11201402396XA (enExample) |
| WO (1) | WO2013079980A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11963716B2 (en) | 2010-07-19 | 2024-04-23 | Emblation Limited | Apparatus and method for the treatment of dermatological diseases or conditions |
| GB201120779D0 (en) * | 2011-12-02 | 2012-01-11 | Immodulon Therapeutics Ltd | Cancer therapy |
| GB201308325D0 (en) * | 2013-05-09 | 2013-06-19 | Immodulon Therapeutics Ltd | Cancer Therapy |
| MX390311B (es) | 2013-12-05 | 2025-03-20 | Rfemb Holdings Llc | Presentacion de antigeno de cancer mejorado a celulas que presentan por la descomposicion electrica de membrana por radiofrecuencia (rf-rmb) como un mecanismo adyuvante para la inmunoterapia. |
| GB201322725D0 (en) | 2013-12-20 | 2014-02-05 | Immodulon Therapeutics Ltd | Cancer therapy |
| CA2975123A1 (en) * | 2015-01-30 | 2016-08-04 | Rfemb Holdings, Llc | Radio frequency electrical membrane breakdown for the treatment of high risk and recurrent prostate cancer, unresectable pancreatic cancer, tumors of the breast, melanoma or other skin malignancies, sarcoma, soft tissue tumors, ductal carcinoma, neoplasia, and intra and extra luminal abnormal tissue |
| CA2990107A1 (en) * | 2015-06-24 | 2016-12-29 | Immodulon Therapeutics Limited | A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy |
| RU2596505C1 (ru) * | 2015-07-02 | 2016-09-10 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России) | Способ лечения онкологических больных цитотоксическими лимфоцитами |
| US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
| TW202428236A (zh) | 2016-01-15 | 2024-07-16 | 美商Ｒｆｅｍｂ控股有限公司 | 癌症之免疫治療 |
| EP3442653A4 (en) * | 2016-04-14 | 2020-02-26 | Feldreich Caro Ruiz AB | DEVICE FOR USE IN RADIATION THERAPY WITH AN IONIZING MODULE AND A UV LIGHT SOURCE |
| SG10202110763WA (en) | 2017-03-28 | 2021-11-29 | Emblation Ltd | Stenosis treatment |
| CN111479571A (zh) | 2017-07-21 | 2020-07-31 | 瓦里安医疗系统公司 | 超高剂量率辐射和治疗剂的使用方法 |
| RU2664597C1 (ru) * | 2017-12-12 | 2018-08-21 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) | Способ комбинированного лечения больных первично операбельным и местно-распространенным неоперабельным раком молочной железы |
| BR112021010799A2 (pt) | 2018-12-03 | 2021-08-24 | Fusion Pharmaceuticals Inc. | Terapia combinada com radioimunoconjugados e inibidor do ponto de verificação |
| US20220098578A1 (en) * | 2019-01-31 | 2022-03-31 | Bar Ilan University | Neoantigens created by aberrant-induced splicing and uses thereof in enhancing immunotherapy |
| WO2021132636A1 (ja) * | 2019-12-27 | 2021-07-01 | 特定非営利活動法人Ｎｏｒｔｈ Ｅａｓｔ Ｊａｐａｎ Ｓｔｕｄｙ Ｇｒｏｕｐ | がん治療方法及び医薬 |
| WO2023007107A1 (en) * | 2021-07-27 | 2023-02-02 | Immodulon Therapeutics Limited | A mycobacterium for use in cancer therapy |
| CN114367060A (zh) * | 2022-01-13 | 2022-04-19 | 深圳大学 | 激光交变电场联合治疗仪 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5207223A (en) | 1990-10-19 | 1993-05-04 | Accuray, Inc. | Apparatus for and method of performing stereotaxic surgery |
| JPH06501479A (ja) * | 1990-11-08 | 1994-02-17 | スタンフオード・ルツク・リミテツド | 抗原担体 |
| US5458125A (en) | 1994-01-28 | 1995-10-17 | Board Of Directors Of The Leland Standford Jr. University | Treatment planning method and apparatus for radiosurgery and radiation therapy |
| CA2369542C (en) | 1999-04-23 | 2009-10-27 | Qlt Inc. | Immuno-adjuvant pdt treatment of metastatic tumors |
| US20020022032A1 (en) | 1999-04-23 | 2002-02-21 | Curry Patrick Mark | Immuno-adjuvant PDT treatment of metastatic tumors |
| AU2002353366A1 (en) * | 2001-12-10 | 2003-06-23 | Bakulesh Mafatlal Khamar | The process of manufacturing a pharmaceutical composition useful for management of cancer |
| AU2003281200A1 (en) | 2002-07-03 | 2004-01-23 | Tasuku Honjo | Immunopotentiating compositions |
| US20050175625A1 (en) | 2002-07-12 | 2005-08-11 | The Johns Hopkins University | Mesothelin vaccines and model systems |
| AU2006306521B2 (en) | 2005-10-21 | 2011-12-22 | Medical College Of Georgia Research Institute, Inc. | The induction of indoleamine 2,3-dioxygenase in dendritic cells by TLR ligands and uses thereof |
| US20080318252A1 (en) | 2007-04-23 | 2008-12-25 | Scott Kachlany | Rapid assay to test anti-cancer drugs under physiological conditions |
| GB0526033D0 (en) | 2005-12-21 | 2006-02-01 | Bioeos Ltd | Method |
| WO2007112316A2 (en) * | 2006-03-24 | 2007-10-04 | Morton Donald L | Mycobacterial immunotherapy for cancer treatment |
| WO2008110491A2 (en) | 2007-03-09 | 2008-09-18 | University Of Basel | Chemotherapy of neoplastic diseases using combinations of rapamycin and compounds modulating mtor pathway alone or in combination with heat |
| NZ600758A (en) | 2007-06-18 | 2013-09-27 | Merck Sharp & Dohme | Antibodies to human programmed death receptor pd-1 |
| DK2172211T3 (en) * | 2008-10-01 | 2015-02-16 | Immatics Biotechnologies Gmbh | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| US8367075B2 (en) | 2010-07-02 | 2013-02-05 | Indian Institute Of Science | Synergistic combination and method thereof |
| AU2012225298B2 (en) * | 2011-03-09 | 2017-05-11 | The Johns Hopkins University | Compounds and methods of use in ablative radiotherapy |
| EP2723381A4 (en) | 2011-06-21 | 2015-03-18 | Univ Johns Hopkins | FOCUSED RADIATION FOR THE REINFORCEMENT OF IMMUNE TREATMENTS AGAINST NEOPLASMS |
| GB201120779D0 (en) * | 2011-12-02 | 2012-01-11 | Immodulon Therapeutics Ltd | Cancer therapy |
| EP2620159A1 (en) | 2012-01-24 | 2013-07-31 | Institut Pasteur | Improved cancer treatment by immunotherapy with bcg or antigenically related non-pathogenic mycobacteria |
| KR20140126357A (ko) | 2012-02-01 | 2014-10-30 | 컴퓨젠 엘티디. | C1orf32 항체 및 이의 암 치료를 위한 용도 |
| US8617520B2 (en) | 2012-02-15 | 2013-12-31 | Immodulon Therapeutics Limited | Cancer therapy |
| GB201308325D0 (en) | 2013-05-09 | 2013-06-19 | Immodulon Therapeutics Ltd | Cancer Therapy |
| GB201322725D0 (en) | 2013-12-20 | 2014-02-05 | Immodulon Therapeutics Ltd | Cancer therapy |
| EP4070818A3 (en) | 2014-01-06 | 2023-01-11 | The Trustees of the University of Pennsylvania | Pd1 and pdl1 antibodies and vaccine combinations and use of same for immunotherapy |
| US10975112B2 (en) | 2015-06-16 | 2021-04-13 | Hangzhou Dac Biotech Co., Ltd. | Linkers for conjugation of cell-binding molecules |
| CA2990107A1 (en) | 2015-06-24 | 2016-12-29 | Immodulon Therapeutics Limited | A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy |
| JP2021529741A (ja) | 2018-06-25 | 2021-11-04 | イモデュロン セラピューティクス リミテッド | がん治療 |
-
2011
- 2011-12-02 GB GBGB1120779.2A patent/GB201120779D0/en not_active Ceased
-
2012
- 2012-12-03 EP EP12799260.0A patent/EP2785361B1/en active Active
- 2012-12-03 US US14/361,992 patent/US20140356397A1/en not_active Abandoned
- 2012-12-03 JP JP2014543984A patent/JP6085611B2/ja active Active
- 2012-12-03 MX MX2014006511A patent/MX2014006511A/es unknown
- 2012-12-03 CN CN201280059421.0A patent/CN104023733A/zh active Pending
- 2012-12-03 BR BR112014012880A patent/BR112014012880A2/pt not_active IP Right Cessation
- 2012-12-03 WO PCT/GB2012/052992 patent/WO2013079980A1/en not_active Ceased
- 2012-12-03 KR KR1020147016935A patent/KR20140097419A/ko not_active Withdrawn
- 2012-12-03 CA CA2857429A patent/CA2857429A1/en not_active Abandoned
- 2012-12-03 SG SG11201402396XA patent/SG11201402396XA/en unknown
- 2012-12-03 RU RU2014121335A patent/RU2014121335A/ru unknown
- 2012-12-03 AU AU2012343536A patent/AU2012343536B2/en active Active
- 2012-12-03 IN IN955MUN2014 patent/IN2014MN00955A/en unknown
-
2014
- 2014-05-29 IL IL232890A patent/IL232890A0/en unknown
-
2018
- 2018-12-19 US US16/225,028 patent/US11318193B2/en active Active
-
2020
- 2020-06-30 US US16/916,194 patent/US11554166B2/en active Active
-
2023
- 2023-01-13 US US18/154,177 patent/US20230149525A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140097419A (ko) | 2014-08-06 |
| EP2785361B1 (en) | 2018-11-28 |
| US20200338181A1 (en) | 2020-10-29 |
| AU2012343536A1 (en) | 2014-06-05 |
| SG11201402396XA (en) | 2014-10-30 |
| WO2013079980A1 (en) | 2013-06-06 |
| MX2014006511A (es) | 2014-12-05 |
| CA2857429A1 (en) | 2013-06-06 |
| RU2014121335A (ru) | 2016-01-27 |
| AU2012343536B2 (en) | 2017-08-24 |
| US11318193B2 (en) | 2022-05-03 |
| IL232890A0 (en) | 2014-07-31 |
| BR112014012880A2 (pt) | 2017-06-13 |
| CN104023733A (zh) | 2014-09-03 |
| US11554166B2 (en) | 2023-01-17 |
| US20190224294A1 (en) | 2019-07-25 |
| JP6085611B2 (ja) | 2017-02-22 |
| GB201120779D0 (en) | 2012-01-11 |
| US20140356397A1 (en) | 2014-12-04 |
| EP2785361A1 (en) | 2014-10-08 |
| NZ624994A (en) | 2016-10-28 |
| US20230149525A1 (en) | 2023-05-18 |
| JP2014533743A (ja) | 2014-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN00955A (enExample) | ||
| Mellal et al. | Thermal therapy modalities for cancer treatment: A review and future perspectives | |
| WO2011137449A3 (en) | Method and apparatus for treatment of ocular tissue using combined modalities | |
| WO2015008154A3 (en) | Self-administrable method, system, and apparatus for non-invasive neurostimulation therapy of the brain | |
| US20240123253A1 (en) | Photodynamic therapy devices, systems and methods | |
| CN102670298A (zh) | 广谱型肿瘤热疗设备 | |
| WO2013166504A3 (en) | Targeted delivery of active agents using thermally stimulated large increase of perfusion by high intensity focused ultrasound | |
| Mooney et al. | Internal temperature increase during photothermal tumour ablation in mice using gold nanorods | |
| Yanase et al. | Hyperthermia enhances the antitumor effect of photodynamic therapy with ALA hexyl ester in a squamous cell carcinoma tumor model | |
| Ross et al. | Laser-tissue interactions | |
| Huang et al. | Therapeutical applications of heat in cancer therapy | |
| Yoo et al. | Non-ablative fractional thulium laser irradiation suppresses early tumor growth | |
| Lloyd et al. | Laser-Tissue Interactions | |
| RU2010129236A (ru) | Способ лечения местнораспространенных онкологических заболеваний в эксперименте | |
| Soni | Heat transfer phenomenon and optical interaction during nanoparticle assisted thermal therapy | |
| PH12015502086A1 (en) | Ablative immunotherapy | |
| Soni et al. | Spatiotemporal Temperature in a Tumor During Nanorod Assisted Thermal Therapy | |
| LUO et al. | Progress on Minimally Invasive Treatment of Localized Prostate Cancer | |
| Lee et al. | Use of a 595-nm pulsed-dye laser to treat post-procedure ecchymoses | |
| Moretti et al. | Conventional and unconventional use of lasers in skin disorders | |
| SU et al. | Mechanism of high intensity focused ultrasound thermal ablation therapy | |
| MX2023012091A (es) | Dispositivos y sistemas para terapia de ablacion. | |
| CN204319538U (zh) | 一种伽玛刀 | |
| CA2722001A1 (en) | Multi-maser ablation therapy (mmat) | |
| Douplik | Combined surgery and photodynamic therapy of cancer |